Pay in 4 interest-free payments of $6.72 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
Pfizer has said it does not expect to return to revenue growth until 2029, as it works to develop new blockbuster drugs, including the obesity treatments it picked up in the $10 billion (NZ$17b) acquisition of Metsera
When starting GLP-1/GIP, youll begin with a 2.5mg starter dose for the first 4 weeks
People who stopped Wegovy regained 6.9% of their body weight
According to the Mass Eye and Ear study: 8.9% of diabetic patients taking semaglutide received a NAION diagnosis
By significantly reducing the incidence of obesity-related comorbidities, semaglutide has the potential to diminish the long-term burden on healthcare resources
When you stop taking GLP-1 medications suddenly, it can result in rapid weight regain
US$ 27.09
US$ 23.30
US$ 22.14
US$ 21.83
US$ 24.55
